Poland· PL-100045442
Tinctura Calendulae Phytopharm
A medicinal product containing calendulae tinctura, registered in Poland by Phytopharm Klęka S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Calendulae tinctura
- Manufacturer
- Phytopharm Klęka S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990087716
- gtin05909990087730
- gtin05909990087723
- gtin05909990087747
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb89e3fa-2903-470d-a624-03af2f341f69 GET /v1/drugs/eb89e3fa-2903-470d-a624-03af2f341f69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu doustnego, do stosowania w jamie ustnej, gardła, na skórę",
"source": "urpl",
"strength": "-",
"packaging": "05909990087716 ¦ OTC ¦ Skasowane ¦ 6793\n1 op. 30 g\n05909990087730 ¦ OTC ¦ Skasowane ¦ 6794\n1 op. 100 g\n05909990087723 ¦ OTC ¦ Skasowane ¦ 15007\n1 op. 45 g\n05909990087747 ¦ OTC ¦ 20954\n1 butelka 100 ml",
"substance": "Calendulae tinctura 187,50 mg/ 5 ml",
"common_name": "Calendulae tinctura",
"pl_product_id": "100045442",
"pozwolenie_nr": "00877",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about calendulae tinctura.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.